Pipeline

NEWS

14 Nov 2017

CONARIS sells filtration technology for stool transplantation

[more]

Forschung_und_Entwicklung_2016_web_en
Pipeline

 

FE 999301

Drug candidate: IL-6 trans-signalling inhibitor, out-licensed to Ferring Pharmaceuticals

CR12/02

Drug candidate: gut microbiota modulator (small molecule)

CR13/01

Drug candidate: intestinal microenvironment transfer / fecal filtrate transfer (sold in 2017)

CR15/01

Diagnostic product candidate for colonoscopy

Conaskin® Tinktur

Cosmetic for oral lesions (marketed since 2013)

Last update: 14 Dezember, 2017

 

Deutsch

 

 

© 2002-2017 Conaris Research Institute AG  I  Impressum I Disclaimer I Terms of Business